ATE391515T1 - Metastasemodelle mit grünfluoreszierendem protein (gfp) als marker - Google Patents

Metastasemodelle mit grünfluoreszierendem protein (gfp) als marker

Info

Publication number
ATE391515T1
ATE391515T1 AT00902334T AT00902334T ATE391515T1 AT E391515 T1 ATE391515 T1 AT E391515T1 AT 00902334 T AT00902334 T AT 00902334T AT 00902334 T AT00902334 T AT 00902334T AT E391515 T1 ATE391515 T1 AT E391515T1
Authority
AT
Austria
Prior art keywords
gfp
tumor
contain
tumors
metastasis
Prior art date
Application number
AT00902334T
Other languages
English (en)
Inventor
Yuying Tan
Takashi Chishima
Original Assignee
Anticancer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22850696&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE391515(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Anticancer Inc filed Critical Anticancer Inc
Application granted granted Critical
Publication of ATE391515T1 publication Critical patent/ATE391515T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0271—Chimeric vertebrates, e.g. comprising exogenous cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0045—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent agent being a peptide or protein used for imaging or diagnosis in vivo
    • A61K49/0047—Green fluorescent protein [GFP]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
    • A61K49/0069—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form
    • A61K49/0097—Cells, viruses, ghosts, red blood cells, viral vectors, used for imaging or diagnosis in vivo
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43595—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from coelenteratae, e.g. medusae
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Pathology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Environmental Sciences (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Genetics & Genomics (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Animal Husbandry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Peptides Or Proteins (AREA)
AT00902334T 1999-01-07 2000-01-07 Metastasemodelle mit grünfluoreszierendem protein (gfp) als marker ATE391515T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/226,856 US6251384B1 (en) 1997-04-28 1999-01-07 Metastasis models using green fluorescent protein (GFP) as a marker

Publications (1)

Publication Number Publication Date
ATE391515T1 true ATE391515T1 (de) 2008-04-15

Family

ID=22850696

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00902334T ATE391515T1 (de) 1999-01-07 2000-01-07 Metastasemodelle mit grünfluoreszierendem protein (gfp) als marker

Country Status (8)

Country Link
US (3) US6251384B1 (de)
EP (1) EP1156833B1 (de)
JP (1) JP3709343B2 (de)
AT (1) ATE391515T1 (de)
AU (1) AU783517B2 (de)
CA (1) CA2358439C (de)
DE (1) DE60038544T2 (de)
WO (1) WO2000040274A1 (de)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050005310A1 (en) * 1999-07-12 2005-01-06 Genentech, Inc. Expression vectors and methods
DE60137501D1 (de) * 2000-03-17 2009-03-12 Anticancer Inc Optisches abbildungssystem zur darstellung der genexpression des gesamten körpers und anwendungen
US7244232B2 (en) * 2001-03-07 2007-07-17 Biomed Solutions, Llc Process for identifying cancerous and/or metastatic cells of a living organism
WO2003006069A1 (en) * 2001-07-09 2003-01-23 Anticancer, Inc. Imaging infection using fluorescent protein as a marker
EP1281767A3 (de) 2001-07-31 2003-05-28 Aladar A. Szalay Lichtausstrahlende Mikroorganismen und Zellen für die Diagnose und Therapie von Tumoren
ATE478556T1 (de) * 2001-09-10 2010-09-15 Anticancer Inc Verbesserte beobachtungsgenauigkeit bei der absiedelung von tumoren
ATE531813T1 (de) * 2001-12-31 2011-11-15 Anticancer Inc System zur überwachung einer bakteriellen tumorbehandlung
US7280680B2 (en) 2002-03-04 2007-10-09 Riken Method and apparatus for observing three-dimensional localizations of in vivo expressed genes as well as method and apparatus for observing minute three-dimensional localizations of in vivo expressed genes
EP1369491A1 (de) * 2002-06-05 2003-12-10 Aladar A. Szalay Lichtemittierende Mikroorganismen und Zellen für die Diagnose und Therapie von Krankheiten assoziiert mit Wunden oder entzündetem Gewebe
US20030228261A1 (en) * 2002-06-05 2003-12-11 Aladar Szalay Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue
DK1534819T3 (da) 2002-08-21 2010-04-19 Revivicor Inc Griselignende dyr, som mangler enhver ekspression af funktionel alfa-1,3-galactosyltransferase
US9453251B2 (en) 2002-10-08 2016-09-27 Pfenex Inc. Expression of mammalian proteins in Pseudomonas fluorescens
WO2004046340A2 (en) * 2002-11-14 2004-06-03 Genentech, Inc. Intron fusion construct and method of using for selecting high-expressing production cell lines
KR101142610B1 (ko) * 2003-02-07 2012-05-10 안티캔서, 인코포레이티드 이중 색상 종양 모델로서의 면역저하된 설치 동물
EP1613160A4 (de) 2003-03-27 2008-01-02 Ptc Therapeutics Inc Betrachtung von enzymen des trna-splice-wegs zur identifikation von antifungalen und/oder proliferationshemmenden molekülen
EP2319318A3 (de) 2003-03-27 2011-08-17 PTC Therapeutics, Inc. Verfahren zur Identifizierung von Verbindungen mit tRNA-Splicing Endonuklease als Aufhänger, und Verwendungen für diese Verbindungen als anti-Proliferationsmittel
US20050039220A1 (en) * 2003-05-27 2005-02-17 Meng Yang Imageable animal model of SARS infection
WO2004109576A1 (en) * 2003-06-09 2004-12-16 National University Of Singapore System and method for providing a service
ATE420160T1 (de) * 2003-06-18 2009-01-15 Genelux Corp Modifizierte rekombinante vacciniaviren, verwendungen davon
US7321791B2 (en) * 2003-09-23 2008-01-22 Cambridge Research And Instrumentation, Inc. Spectral imaging of deep tissue
US8634607B2 (en) 2003-09-23 2014-01-21 Cambridge Research & Instrumentation, Inc. Spectral imaging of biological samples
US7155274B1 (en) 2003-11-21 2006-12-26 Imaging Diagnostic Systems, Inc. Optical computed tomography scanner for small laboratory animals
WO2005099363A2 (en) 2004-03-26 2005-10-27 Whitehead Institute For Biomedical Research Methods of diagnosing, preventing and treating cancer metastasis
BRPI0513826A2 (pt) 2004-07-26 2010-06-22 Dow Global Technologies Inc processo para expressão de proteìna melhorada através de engenharia de cepa
WO2006081547A1 (en) 2005-01-27 2006-08-03 Cambridge Research And Instrumentation, Inc. Classifying image features
EP3138403A1 (de) 2005-08-09 2017-03-08 Revivicor, Inc. Ctla4-ig exprimierende transgene huftiere und verwendungen davon
WO2007070784A2 (en) * 2005-12-12 2007-06-21 The Uab Research Foundation Fluorescent detection of cancer and fluorescent guided surgical removal
EP2037270A3 (de) * 2006-03-31 2009-03-25 F. Hoffmann-La Roche Ag Tumormodell unter Verwendung von grünem Fluoreszenzprotein
TW200819540A (en) 2006-07-11 2008-05-01 Genelux Corp Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders
EP2097517B1 (de) 2006-10-16 2014-06-04 Genelux Corporation Rekombinantes Lister-Stamm Vaccinia Virus kodierend für einen einzelkettigen anti-VEGF Antikörper
WO2008079228A1 (en) * 2006-12-20 2008-07-03 Danisco Us, Inc., Genencor Division Assays for improved fungal strains
US9394571B2 (en) 2007-04-27 2016-07-19 Pfenex Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
US9580719B2 (en) 2007-04-27 2017-02-28 Pfenex, Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
CA2690627C (en) * 2007-06-15 2014-12-02 Genelux Corporation Microorganisms for imaging and/or treatment of tumors
CA2700543A1 (en) * 2007-10-01 2009-04-09 Anticancer, Inc. Imageable rodent model of asthma
US20120052003A9 (en) * 2008-05-16 2012-03-01 Szalay Aladar A Microorganisms for preventing and treating neoplasms accompanying cellular therapy
WO2010006168A2 (en) * 2008-07-09 2010-01-14 University Of Rochester Methods of treating cancer using and agent that modulates activity of the calcitonin-gene related peptide ("cgrp") receptor
ES2733211T3 (es) 2011-04-15 2019-11-28 Genelux Corp Cepas clonales de virus vaccinia atenuados y métodos de uso de las mismas
WO2013052915A2 (en) 2011-10-05 2013-04-11 Genelux Corporation Method for detecting replication or colonization of a biological therapeutic
JP6436669B2 (ja) * 2014-07-22 2018-12-12 国立大学法人福井大学 子宮肉腫転移モデル動物
USD809116S1 (en) 2015-11-02 2018-01-30 Pura Scents Dispenser
USD816506S1 (en) 2015-11-02 2018-05-01 Pura Scents, Inc. Vial for a scent dispenser
US9827343B2 (en) 2015-11-02 2017-11-28 Pura Scents, Inc. Scent dispensation and fluid level sensing
WO2019094107A2 (en) * 2017-09-18 2019-05-16 President And Fellows Of Harvard College Human in vitro orthotopic and metastatic models of cancer
CN116539862B (zh) * 2022-07-20 2024-03-12 成都诺医德医学检验实验室有限公司 一种基于类器官共生长平台测试肿瘤转移能力的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5491084A (en) * 1993-09-10 1996-02-13 The Trustees Of Columbia University In The City Of New York Uses of green-fluorescent protein
US5650135A (en) * 1994-07-01 1997-07-22 The Board Of Trustees Of The Leland Stanford Junior University Non-invasive localization of a light-emitting conjugate in a mammal
US5874304A (en) * 1996-01-18 1999-02-23 University Of Florida Research Foundation, Inc. Humanized green fluorescent protein genes and methods
CA2257148A1 (en) 1996-05-31 1997-12-04 Wei-Wei Zhang Mini-adenoviral vector
EP0979298B1 (de) 1997-04-28 2008-06-11 Anticancer, Inc. Metastasemodelle unter verwendung des grün-fluoreszierenden proteins

Also Published As

Publication number Publication date
JP2002534398A (ja) 2002-10-15
WO2000040274A1 (en) 2000-07-13
DE60038544T2 (de) 2009-07-09
US6251384B1 (en) 2001-06-26
CA2358439A1 (en) 2000-07-13
US20020026649A1 (en) 2002-02-28
DE60038544D1 (de) 2008-05-21
US20040191173A1 (en) 2004-09-30
EP1156833A1 (de) 2001-11-28
JP3709343B2 (ja) 2005-10-26
CA2358439C (en) 2010-06-29
US6759038B2 (en) 2004-07-06
AU783517B2 (en) 2005-11-03
EP1156833B1 (de) 2008-04-09
AU2406900A (en) 2000-07-24

Similar Documents

Publication Publication Date Title
ATE391515T1 (de) Metastasemodelle mit grünfluoreszierendem protein (gfp) als marker
ATE398183T1 (de) Metastasemodelle unter verwendung des grün- fluoreszierenden proteins
CA2289283A1 (en) Metastasis models using green fluorescent protein (gfp) as a marker
Hebert et al. Dissecting metastasis using preclinical models and methods
Wan et al. Molecular imaging in the second near‐infrared window
Zhou et al. Emerging strategies to investigate the biology of early cancer
Daphu et al. In vivo animal models for studying brain metastasis: value and limitations
Bhuta et al. Myxoid malignant melanoma: a previously undescribed histologic pattern noted in metastatic lesions and a report of four cases
Lee et al. In vivo imaging using polymeric nanoparticles stained with near-infrared chemiluminescent and fluorescent squaraine catenane endoperoxide
ES2179196T3 (es) Complejos radiofarmacos ternarios.
ATE318314T1 (de) Verfahren zur bestimmung des metastasierungspotentials unter verwendung des asp1 gens
Hoffman Imaging cancer dynamics in vivo at the tumor and cellular level with fluorescent proteins
ATE229073T1 (de) Protein e25a, methoden zu dessen herstellung und anwendung
Sun et al. Preclinical advances with multiphoton microscopy in live imaging of skin cancers
ATE455853T1 (de) Antikörper gegen geschädigtes gewebe
Kosaka et al. In vivo stable tumor-specific painting in various colors using dehalogenase-based protein-tag fluorescent ligands
DE602004031368D1 (de) Universelle vervielfältigung von fragmentierter rns
Zhou et al. A mitochondria targetable two-photon excited near-infrared fluorescent probe for imaging of H2O2 in live cells and tissues
Rios et al. Multidimensional imaging of breast cancer
WO2010096044A1 (en) In vivo quantitative screening test for anti-metastasis treatment efficacy
Tomas et al. Myofibroblastic stromal reaction and expression of tenascin-C and laminin in prostate adenocarcinoma
CN116178355A (zh) 一种检测硫醇的化学发光试剂、合成方法及应用
EA200601405A1 (ru) Гуманизированное антитело
DE60221115D1 (de) Zusammensetzungen und verfahren zur verwendung von fibronektin-fragmenten bei krebsdiagnose
ATE306668T1 (de) Diagnose von brustkrebs unter verwendung von bcmp-7 als marker

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties